NCT03347279NCT05274815tezepelumabsevere asthmasevere uncontrolled asthma
… In the phase 3 NAVIGATOR study in severe uncontrolled asthma ( NCT03347279), 28.5% of tezepelumab recipients achieved on-treatment clinica…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT03347279 ×
NCT03347279
This institution is selected. Its supporting articles are shown below.